Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Dose adjustments can be made after 4-6 weeks based on rate of progress and tolerance
As a result, many healthcare systems have integrated telehealth into their standard practices, making it a permanent fixture in the healthcare landscape
Here is a summary of the data for Utah : Share of all patients who take a GLP-1: 0.7% Share of patients with an obesity diagnosis who take a GLP-1: 4.8% Share of male patients with an obesity diagnosis who take a GLP-1: 4.4% Share of female patients with an obesity diagnosis who take a GLP-1: 5.1% Share of GLP-1 users that are female: 60.4% For reference, here are the statistics for the entire United States: Share of all patients who take a GLP-1: 1.0% Share of patients with an obesity diagnosis who take a GLP-1: 4.8% Share of male patients with an obesity diagnosis who take a GLP-1: 4.2% Share of female patients with an obesity diagnosis who take a GLP-1: 5.2% Share of GLP-1 users that are female: 64.7% For more information, a detailed methodology, and complete results, see U.S
Track body measurements Log waist, chest, hips, arms, thighs, and neck so you can see non-scale changes as your body shape shifts
Because they are not rigorously studied, a full side effect profile is often unknown
Are providers board-certified in obesity medicine, endocrinology, or family medicine
